je.st
news
Home
› Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis
Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis
2014-12-29 01:32:30| drugdiscoveryonline Home Page
Microchips Biotech, Inc., formerly MicroCHIPS, Inc., recently announced the completion of the development and clinical demonstration of its proprietary drug delivery technology, a microchip-based implant capable of storing and releasing precise doses of a drug on-demand or at scheduled intervals for up to 16 years
Tags: and
development
delivery
efforts
Category:Biotechnology and Pharmaceuticals